Juan G. Zhen

Changchun, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Current status of pharmacotherapy for primary sclerosing cholangitis.

Current status of pharmacotherapy for primary sclerosing cholangitis.

Journal: Frontiers in medicine

Published: December 13, 2024

High-density lipoprotein mimetic nano-therapeutics targeting monocytes and macrophages for improved cardiovascular care: a comprehensive review.

High-density lipoprotein mimetic nano-therapeutics targeting monocytes and macrophages for improved cardiovascular care: a comprehensive review.

Journal: Journal of nanobiotechnology

Published: December 12, 2023

Histone acetyltransferase Kat2a regulates ferroptosis via enhancing Tfrc and Hmox1 expression in diabetic cardiomyopathy.

Histone acetyltransferase Kat2a regulates ferroptosis via enhancing Tfrc and Hmox1 expression in diabetic cardiomyopathy.

Journal: Cell death & disease

Published: November 21, 2023

Ginsenoside RG1-induced mesenchymal stem cells alleviate diabetic cardiomyopathy through secreting exosomal circNOTCH1 to promote macrophage M2 polarization.

Ginsenoside RG1-induced mesenchymal stem cells alleviate diabetic cardiomyopathy through secreting exosomal circNOTCH1 to promote macrophage M2 polarization.

Journal: Phytotherapy research : PTR

Published: October 29, 2022

Retraction notice to "Astragaloside IV protects cardiomyocytes from hypoxia-induced injury by down-regulation of lncRNA GAS5" [Biomed. Pharmacother. 116 (2019) 109028].

Retraction notice to "Astragaloside IV protects cardiomyocytes from hypoxia-induced injury by down-regulation of lncRNA GAS5" [Biomed. Pharmacother. 116 (2019) 109028].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 14, 2022

Rg1 protects H9C2 cells from high glucose-/palmitate-induced injury via activation of AKT/GSK-3β/Nrf2 pathway.

Rg1 protects H9C2 cells from high glucose-/palmitate-induced injury via activation of AKT/GSK-3β/Nrf2 pathway.

Journal: Journal of cellular and molecular medicine

Published: March 09, 2020

Zinc as a countermeasure for cadmium toxicity.

Zinc as a countermeasure for cadmium toxicity.

Journal: Acta pharmacologica Sinica

Published: December 19, 2019

Glatiramer acetate protects against oxygen-glucose deprivation/reperfusion-induced injury by inhibiting Egr-1 in H9c2 cells.

Glatiramer acetate protects against oxygen-glucose deprivation/reperfusion-induced injury by inhibiting Egr-1 in H9c2 cells.

Journal: Molecular immunology

Published: October 12, 2019

Neonatal murine engineered cardiac tissue toxicology model: Impact of dexrazoxane on doxorubicin induced injury.

Neonatal murine engineered cardiac tissue toxicology model: Impact of dexrazoxane on doxorubicin induced injury.

Journal: Life sciences

Published: August 16, 2019

Zinc protects against cadmium-induced toxicity in neonatal murine engineered cardiac tissues via metallothionein-dependent and independent mechanisms.

Zinc protects against cadmium-induced toxicity in neonatal murine engineered cardiac tissues via metallothionein-dependent and independent mechanisms.

Journal: Acta pharmacologica Sinica

Published: May 22, 2019

RETRACTED: Astragaloside IV protects cardiomyocytes from hypoxia-induced injury by down-regulation of lncRNA GAS5.

RETRACTED: Astragaloside IV protects cardiomyocytes from hypoxia-induced injury by down-regulation of lncRNA GAS5.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 02, 2019

A sensitive LC-MS/MS-based bioanalytical method for quantification of salviaflaside and rosmarinic acid in rat plasma and its application in a pharmacokinetic study.

A sensitive LC-MS/MS-based bioanalytical method for quantification of salviaflaside and rosmarinic acid in rat plasma and its application in a pharmacokinetic study.

Journal: Biomedical chromatography : BMC

Published: January 10, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026